相关实验视频
Updated: May 12, 2026
08:43
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
67.0K
患有炎症性肠道疾病的患者中风风险:系统性审查和元分析
Chao Luo1, Lingpei Liu1, Di Zhu1
1Department of General Practice, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua Municipal Central Hospital, Jinhua, Zhejiang, 321000, China.
BMC gastroenterology
|February 25, 2025
概括
炎症性肠病 (IBD) 患者面临更高的中风风险. 克罗恩氏病 (CD) 比性结肠炎 (UC) 具有更大的风险,这强调了在IBD护理中需要进行心血管监测的必要性.
科学领域:
- 胃肠病学 胃肠病学
- 心脏病学 心脏病学
- 流行病学 流行病学
背景情况:
- 越来越多的证据将炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),与心血管疾病风险增加联系在一起.
- 在这种协会中,中风是一个重大问题,需要对IBD患者群体进行进一步的研究.
研究的目的:
- 与一般人群相比,系统地评估和量化被诊断为IBD的个体中风的风险.
- 在更广泛的IBD类别中,区分克罗恩病 (CD) 和性结肠炎 (UC) 亚型之间的中风风险.
主要方法:
- 在主要数据库 (PubMed,Embase,CENTRAL,Scopus,CINAHL) 进行了全面的系统文献搜索,截至2023年9月.
- 使用随机效应模型的元分析被用于计算中风发生的聚合危险比率 (HRs) 和95%置信区间 (CI).
- 对CD,UC和整体IBD进行了子组分析,使用Begg和Egger测试评估了出版偏差.
主要成果:
- 分析包括13项研究,涉及2,802,955名参与者.
- 在IBD患者中,中风风险显著增加 (HR: 1.30,95% CI: 1.21-1.39).
- 亚组分析显示,CD (HR: 1.35,95% CI: 1.22-1.49) 和UC (HR: 1.15,95% CI: 1.09-1.22) 的中风风险更高.
结论:
- 无论是IBD总体还是克罗恩病,都与中风风险的统计显著增加有关.
- 这些发现凸显了综合性心血管风险评估和IBD患者日常护理中的积极管理策略的关键需求.
相关概念视频
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:26Inflammatory Bowel Disease I: Introduction
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...